Contract manufacturing set for major growth spurt

Contract manufacturing is set to more than double by 2021, and grow to $64.07 billion by 2016. Manufacturing of finished drugs will grow the most, according to a new report from Visiongain. Report

Suggested Articles

J&J's talc woes deepened Friday after the FDA turned up "sub-trace" levels of asbestos one bottle of the company's baby powder,…

Another major drugmaker is recalling in the U.K. 10 batches of its Zantac generics because they contain a possible carcinogen.

With diagnosis rates on the rise, Pfizer's Vyndaqel franchise could collect $157 million in 2019 U.S. sales, well above consensus, SVB Leerink says.